Syndax Pharmaceuticals Income Statement (2015-2026) | SNDX

Income Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
Operating items
Research & Development (Quarter)
2.00M15.00M10.00M
Selling, General & Administrative (Quarter)
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)
2.00M15.00M10.00M
Operating Income (Quarter)
EBIT (Quarter)
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)
Net income details
EBT (Quarter)
Profit After Tax (Quarter)
Income from Continuing Operations (Quarter)
Consolidated Net Income (Quarter)
Income towards Parent Company (Quarter)
Net Income towards Common Stockholders (Quarter)
Additional items
EPS (Basic) (Quarter)
Shares Outstanding (Weighted Average) (Quarter)
51.55M51.96M52.06M58.98M59.57M60.67M60.76M69.44M69.64M69.86M70.37M85.21M85.24M85.31M85.62M86.17M86.34M86.53M86.63M88.26M
EBITDA (Quarter)